Company Filing History:
Years Active: 2000
Title: Michaela Scherr: Innovator in Enzymatic RNA Molecules
Introduction
Michaela Scherr is a prominent inventor based in Oberursel, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of enzymatic RNA molecules. Her work focuses on innovative solutions for treating diseases associated with abnormal cell growth and differentiation.
Latest Patents
Michaela Scherr holds a patent for "Enzymatic RNA molecules that cleave mutant N-RAS." This invention involves the design of enzymatic RNA molecules that specifically cleave mutant N-RAS mRNA, preferably at a NUX cleavage site. The preferred ribozymes have nucleotide sequences 5'-CCAACACCUGAUGAGCGUUAGCGAAACCUGCU-3' or 5'-UCCCAACCUGAUGAGCGUUAGCGAAACACCUG-3' (SEQ ID NOS:1 and 2), along with their derivatives. The invention also encompasses pharmaceuticals containing such molecules and their application in treating diseases related to abnormal cell growth.
Career Highlights
Michaela Scherr has been associated with Hoechst Aktiengesellschaft, where she has contributed her expertise in biotechnology and molecular biology. Her innovative work has positioned her as a key figure in her field, demonstrating a commitment to advancing medical science through her inventions.
Collaborations
Michaela has collaborated with notable colleagues, including Eugen Uhlmann and Joachim Engels. These partnerships have further enhanced her research and development efforts, leading to impactful advancements in enzymatic RNA technology.
Conclusion
Michaela Scherr's contributions to the field of enzymatic RNA molecules exemplify her dedication to innovation in biotechnology. Her patent for cleaving mutant N-RAS mRNA represents a significant step forward in the treatment of diseases involving abnormal cell growth.